This inventor holds 2 USPTO granted patents. Top assignee: Cellfree Sciences Co., Ltd.. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Hirohisa Koga: Innovator in Cell-Free Protein Synthesis
Introduction
Hirohisa Koga, a prominent inventor based in Yokohama, Japan, has made significant contributions to the field of protein synthesis. With a total of two patents to his name, Koga focuses on methods that enhance the efficiency and effectiveness of cell-free protein synthesis.
Latest Patents
Koga's latest patents revolve around innovative methods for producing cell extracts that facilitate cell-free protein synthesis. His patented process involves removing substances that bind to an affinity support used in purification or interaction analysis from a cell extract with protein synthetic activity. This method allows for the synthesis of target proteins, which can subsequently be purified using affinity support and applied in interaction analysis. This advancement not only streamlines the protein synthesis process but also enhances the potential for further research and applications in biotechnology.
Career Highlights
Koga is associated with Cellfree Sciences Co., Ltd., a company dedicated to advancing cell-free technologies. His work at the company underscores a commitment to innovation in protein synthesis, aimed at benefiting various scientific and industrial applications.
Collaborations
Throughout his career, Koga has collaborated with fellow innovator Yoshiko Yoshiyama, contributing to the development and advancement of their shared research interests. Their partnership highlights the importance of teamwork in driving innovation within the field.
Conclusion
Hirohisa Koga's contributions to cell-free protein synthesis underline the vital role of inventors in scientific progress. With his two patents, Koga continues to pave the way for more efficient methods in biotechnology, promoting advancements that could benefit both research institutions and industry alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
